Winton Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-45,500
Closed -$104K 1409
2026
Q1
$104K Buy
45,500
+25,500
+128% +$58.7K ﹤0.01% 1039
2025
Q4
$56K Buy
+20,000
New +$71.5K ﹤0.01% 900
2025
Q3
Sell
-37,302
Closed -$339K 947
2025
Q2
$339K Sell
37,302
-153,960
-80% -$1.13M 0.02% 672
2025
Q1
$1.73M Buy
+191,262
New +$2.02M 0.11% 205
2022
Q1
Sell
-21,057
Closed -$916K 1102
2021
Q4
$916K Buy
+21,057
New +$826K 0.06% 491
2014
Q4
Sell
-8,937
Closed -$293K 654
2014
Q3
$293K Sell
8,937
-14,847
-62% -$505K ﹤0.01% 632
2014
Q2
$808K Buy
+23,784
New +$815K 0.01% 560

Other funds holding ACH

Winton Group's ACH Position: Q2 2026 in Review

Winton Group sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 45,500 shares — an estimated $104K sold.

Winton Group first reported a position in ACH in Q2 2014 and held it in 7 quarters. The position peaked at $1.73M in Q1 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Winton Group reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 45,500 Accendra Health shares in Q2 2026, an estimated $104K.
  • Winton Group first reported a position in Accendra Health in Q2 2014 and held it in 7 quarters.
  • Winton Group's Accendra Health position peaked at $1.73M in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.